Increased Risk of Gallstones and Pancreatitis Patients taking GLP-1 medications are at higher risk of developing gallstones and gallbladder disease requiring surgery
Patients were considered persistent until evidence of discontinuation with no gaps between two consecutive prescriptions of more than 30 days for non-insulin agents and more than 3 months for insulin
Its inconvenient, time-consuming, and often irritating for your skin
individuals may be left with loose, hanging skin in areas like the breasts, back, and abdomen
Personalized treatment options For patients with cancers like breast, ovarian, pancreatic and prostate, identifying genetic mutations (like BRCA mutations) can open the door to personalized therapies
Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify